|
Recent Developments |
|
26-JUN-15
Sun Pharmaceutical Industries, an international, integrated, speciality pharmaceutical company, makes an open offer to public shareholders of Zenotech Laboratories to acquire 96,93,332 equity shares of Rs 10 each at a price of Rs 20.87 a share representing 28.16% of the voting equity share capital of the company as on July 25, 2015.
... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2016(6) | 31-Mar-2016(12) | 31-Mar-2015 (12) | | Net sales | 1.68 | 20.60 | 40.77 | | Other Income | 0.35 | 3.88 | 3.45 | | Total Income | 2.03 | 24.48 | 44.22 | | Cost of goods sold | 38.60 | 110.40 | 241.27 | | OPBDIT | -36.57 | -85.92 | -197.05 | | PAT | -55.26 | -191.09 | -304.14 | | Gross Block | - | - | - | | Equity capital | - | 344.28 | 344.28 | | EPS (Rs.) | - | - | -8.83 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | -1801.5 | -351.0 | -445.6 | | Net margin (% of OI) | -2722.2 | -780.6 | -687.8 |
|
|
Detailed Financials
|
|
|
|
|
